Gelinya (fingolimod) FDA approved
- Details
- Category: Medications
- Written by R. Adam Quigley
- Hits: 3322
* mild immunosuppressive/immunomodulatory medication in pill form
* good safety profile, but some risks require consideration and monitoring
* first dose usually give in doctors office
* 1:200 risk of eye (macula) swelling
* 1:200 risk of symptoms with slow heart rate on first dose
* Need to have had chickenpox or vaccine at least 30 days before
* Monitr for liver stress
* Need bullet-proof reliable contraceptive



Ultrahigh-field strength, T1-weighted magnetization-prepared rapid acquisition and multiple gradient echoes (MPRAGE) is highly sensitive for detecting multiple sclerosis (MS) plaques within the white and gray brain parenchyma, according to a study published online Feb. 20 in Archives of Neurology, one of the JAMA/Archives...
Cannabis-based medicinal products, such as Sativex, could soon be available to sufferers of Multiple Sclerosis (MS) and other medical conditions on prescription.
One in a lakh Indians is thought to suffer from multiple sclerosis, a life-long disorder of the nervous system. Support groups are lobbying to bring the disease under the Disability Act, and are fighting for insurance cover.



